United States

Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

2:49pm EDT
Change (% chg)

$-0.26 (-0.78%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

India's Dr.Reddy's Laboratories Sept-qtr consol PAT down about 1 pct
Tuesday, 31 Oct 2017 02:01am EDT 

Oct 31 (Reuters) - Dr.Reddy's Laboratories Ltd ::Sept quarter consol net profit after tax 3.05 billion rupees versus 3.09 billion rupees last year.Consensus forecast for sept quarter consol profit was 2.88 billion rupees.Sept quarter consol net sales 34.91 billion rupees versus 35.29 billion rupees last year.Expect to see results from products launched in U.S. during first half of the fiscal‍​.  Full Article

Dr.Reddy's Labs gets EIR from U.S. FDA for plant in Andhra Pradesh
Thursday, 28 Sep 2017 12:59am EDT 

Sept 28 (Reuters) - Dr.Reddy's Laboratories Ltd :Says gets EIR from U.S. FDA for formulation Srikakulam plant (SEZ) unit 1, Andhra Pradesh.  Full Article

Dr.Reddy's Laboratories says class action lawsuit filed against co
Monday, 28 Aug 2017 12:39am EDT 

Aug 28 (Reuters) - Dr.Reddy's Laboratories Ltd ::Says law firm representing an investor in co filed class action lawsuit against company its CEO, and CFO.Co cannot comment on the specific allegations in the pending litigation.Says has not yet been served with the lawsuit.Says "believes the asserted claims to be without merit".Class action lawsuit filed in U.S. district court of New Jersey for alleged violations of U.S. federal securities laws.  Full Article

Dr Reddy's says U.S. court finds co's product infringes some patents
Wednesday, 15 Feb 2017 11:14pm EST 

Dr.Reddy's Laboratories Ltd : Says Dr. Reddy's Laboratories announces U.S. district court's opinion relating to patent infringement . Court found that asserted claims of the "094" and "980" patents were not invalid .Court found that co's proposed palonosetron hydrochloride product infringes certain claims of some U.S. patents.  Full Article

Dr.Reddy's Labs exec says co has addressed all FDA requirements on warning letters
Tuesday, 25 Oct 2016 09:33am EDT 

Dr.Reddy's Laboratories Ltd : Exec says have addressed all FDA requirements on warning letters . Exec says pricing erosion has become a part of U.S. business model Further company coverage: [REDY.NS] (Bengaluru newsroom) ((ReutersIndia.snapping@thomsonreuters.com ;)).  Full Article

Dr.Reddy's Labs announces entry into Columbia
Friday, 7 Oct 2016 09:11am EDT 

Dr.Reddy's Laboratories Ltd :Announces entry into Columbia.  Full Article

DR. Reddy's laboratories says launch of Bupropion HCL extended-release tablets, USP (sr) in U.S. market
Friday, 2 Sep 2016 11:32am EDT 

Dr.Reddy's Laboratories Ltd :Launch of bupropion hcl extended-release tablets, usp (sr) in u.s. Market.  Full Article

Dr.Reddy's Laboratories says June-qtr consol net profit falls about 76.2 pct
Tuesday, 26 Jul 2016 05:12am EDT 

Dr.Reddy's Laboratories Ltd : June -quarter pat 4.09 billion rupees - tv . June -quarter consol net profit 1.54 billion rupees; consol net sales inr 31.64 billion . Consensus forecast for June-quarter profit was 4.95 billion rupees . Consol net profit in June-quarter last year was 6.47 billion rupees as per Ind-AS; consol net sales was 37.01 billion rupees . In quarter, top and bottom lines impacted by fall in volume growth, mainly in U.S. markets, loss of business in Venezuela . Co faced challenges in quarter including price erosion and delayed launches due to warning letter, which significantly impacted earnings .  Full Article

Spectrum Pharma says Dr Reddy's will be permitted to market generic version of Folotyn in US on Dec 1, 2022 or earlier
Tuesday, 31 May 2016 07:02am EDT 

Spectrum Pharmaceuticals : Co's unit, dr. Reddy's labs, ltd entered into settlement agreement to resolve their patent litigation relating to folotyn .dr. Reddy's will be permitted to market generic version of folotyn in u.s. On december 1, 2022 or earlier under certain circumstances.  Full Article

Dr. Reddy's Labs acquires six OTC brands from Ducere Pharma
Wednesday, 25 May 2016 05:27am EDT 

Dr.Reddy's Laboratories Ltd : Dr. Reddy's enters the branded consumer health arena through the acquisition of six OTC brands . Co acquired six OTC brands from Ducere Pharma .  Full Article